Efficacy of Solanezumab in Early Alzheimer’s Disease: A Systematic Review and Meta Analysis

Despite solanezumab worsening biomarkers levels, the data suggests that solanezumab has a limited efficacy to improve the cognitive function of participants with early AD.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2025-12-01
DOI
https://doi.org/10.1002/alz70859_103207
Primary Topic
Alzheimer's disease research and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy of Solanezumab in Early Alzheimer’s Disease: A Systematic Review and Meta Analysis

Mohamed Nasim., Youssef A. Ismail, Mahmoud Orhan, Muataz El‐Barbari et al.
Alzheimer s & Dementia
Alzheimer's disease research and treatments
article

Efficacy of Solanezumab in Early Alzheimer’s Disease: A Systematic Review and Meta Analysis

Mohamed Nasim., Youssef A. Ismail, Mahmoud Orhan, Muataz El‐Barbari, Youssef M. Seddeik
article en

Abstract

Despite solanezumab worsening biomarkers levels, the data suggests that solanezumab has a limited efficacy to improve the cognitive function of participants with early AD.

Alzheimer s & DementiaVol. 21(S5)
Port Said University (EG)
Openalex Percentile: Top 33%
Alzheimer's disease research and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Efficacy of Solanezumab in Early Alzheimer’s Disease: A Systematic Review and Meta Analysis — Mohamed Nasim., Youssef A. Ismail, et al. · Alzheimer s & Dementia (2025) | TGRS Research Map | TGRS